Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Myla Strawderman

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|February 9, 2022
Early postoperative ERAS compliance predicts decreased length of stay and complications following liver resectionPaul R Burchard, Yatee A Dave, Anthony P Loria, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
PSP-0119: Targeted IRAK4 Degradation as a Novel Therapeutic Strategy for FLT3-Mutant AMLNegar Khazan, Cameron Wa Snyder, Chandhana Ravi, et al.
Eclinicalmedicine|December 16, 2024
Vitamin D in patients with low tumor-burden indolent non-Hodgkin lymphoma treated with rituximab therapy (ILyAD): a randomized, phase 3 clinical trialJonathan W Friedberg, Michael T Brady, Myla Strawderman, et al.
Leukemia & Lymphoma|August 6, 2025
Characterizing primary mediastinal large B-cell lymphoma based on molecular classification: a multi-center retrospective pilot studyMichael A Superdock, Lisa M Rimsza, Danielle S Wallace, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
IL1β/IL1R1/IRAK4 Drives Inflammatory Ovarian Cancer Seeding at the inflamed sites and Is Reversed by an IRAK4 inhibitor UR241-2John P Miller, Kyu Kwang Kim, Cameron Wa Snyder, et al.
Biorxiv : the Preprint Server for Biology|June 22, 2026
Reconstruction of septin higher-order nano-size structures in ovarian cancer cells uncover susceptibility to the septin-targeting small molecule UR214-9Negar Khazan, Cameron Wa Snyder, Nicole Dawney, et al.
Journal of Medicinal Chemistry|April 11, 2022
Identification of a Vitamin-D Receptor Antagonist, MeTC7, which Inhibits the Growth of Xenograft and Transgenic Tumors <i>In Vivo</i>Negar Khazan, Kyu Kwang Kim, Jeanne N Hansen, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|February 9, 2022
Early postoperative ERAS compliance predicts decreased length of stay and complications following liver resectionPaul R Burchard, Yatee A Dave, Anthony P Loria, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
PSP-0119: Targeted IRAK4 Degradation as a Novel Therapeutic Strategy for FLT3-Mutant AMLNegar Khazan, Cameron Wa Snyder, Chandhana Ravi, et al.
Eclinicalmedicine|December 16, 2024
Vitamin D in patients with low tumor-burden indolent non-Hodgkin lymphoma treated with rituximab therapy (ILyAD): a randomized, phase 3 clinical trialJonathan W Friedberg, Michael T Brady, Myla Strawderman, et al.
Leukemia & Lymphoma|August 6, 2025
Characterizing primary mediastinal large B-cell lymphoma based on molecular classification: a multi-center retrospective pilot studyMichael A Superdock, Lisa M Rimsza, Danielle S Wallace, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
IL1β/IL1R1/IRAK4 Drives Inflammatory Ovarian Cancer Seeding at the inflamed sites and Is Reversed by an IRAK4 inhibitor UR241-2John P Miller, Kyu Kwang Kim, Cameron Wa Snyder, et al.
Biorxiv : the Preprint Server for Biology|June 22, 2026
Reconstruction of septin higher-order nano-size structures in ovarian cancer cells uncover susceptibility to the septin-targeting small molecule UR214-9Negar Khazan, Cameron Wa Snyder, Nicole Dawney, et al.
Journal of Medicinal Chemistry|April 11, 2022
Identification of a Vitamin-D Receptor Antagonist, MeTC7, which Inhibits the Growth of Xenograft and Transgenic Tumors <i>In Vivo</i>Negar Khazan, Kyu Kwang Kim, Jeanne N Hansen, et al.
Pageof 4